Therapeutic methods using an ti-CD200 antibodies

Details for Australian Patent Application No. 2011215750 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Rother, Russell P.; Yan, Yan

Agent Shelston IP

Pub. Number AU-A-2011215750

PCT Pub. Number WO2011/100538

Priority 61/337,962 11.02.10 US

Filing date 11 February 2011

Wipo publication date 18 August 2011

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/100538 Priority application(s): WO2011/100538

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011215752-Access control and congestion control in machine-to-machine communication

2011215743-Method for applying full back surface field and silver busbar to solar cell